Compare

Aveanna Healthcare/$AVAH

1D1W1M3M6MYTD1Y5YMAX

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.
Ticker
$AVAH
Sector
Health
Primary listing
NASDAQ
Employees
19,500

AVAH Metrics

BasicAdvanced
$2.7B
10.21
$1.23
1.97
-

What the Analysts think about AVAH

Analyst ratings (Buy, Hold, Sell) for Aveanna Healthcare stock.
Analyst projections of the future price of Aveanna Healthcare stock.

Bulls say / Bears say

Aveanna’s second-quarter revenue rose 13.7% year on year and adjusted EBITDA rose 8.0%. Management raised 2026 guidance to more than $2.68bn of revenue and $365m of adjusted EBITDA, showing that recent execution is ahead of its earlier plan. (BioSpace, Last10K)
The preferred-payer strategy and state rate work are beginning to improve growth and capacity. Private Duty Services had 37 preferred payer agreements covering 64% of managed-care volume, while management raised its long-term organic growth targets for both Private Duty Services and Home Health & Hospice. (The Motley Fool, TradingKey)
Home Health & Hospice offers a faster-growing route for the group. Episodes rose 18.5% year on year with an 81% episodic mix, and management plans to use further, valuation-disciplined acquisitions alongside organic growth after buying Family First Homecare. (Home Health Care News, Hospice News)
Aveanna remains exposed to policy and reimbursement decisions it cannot control. Its latest filing highlights dependence on Medicare, Medicaid and managed-care payments, including the risk that Medicaid changes and lower rates could materially hurt results. (Last10K, BioSpace)
Caregiver availability is still the main capacity constraint, and higher wages can absorb reimbursement gains. California’s rate increase is not effective until January 2027, yet Aveanna plans to raise wages beforehand; management also said California fill rates had fallen by almost 30%. (TradingKey, The Motley Fool)
The balance sheet leaves less room for execution mistakes. Aveanna funded the $173.7m Family First purchase with cash, still carries substantial term debt and receivables financing, and will need successful integration and sustained cash generation to reach its target of leverage below three times. (StockTitan, TradingKey)
Data summarised monthly by Lightyear AI. Last updated on 16 Sept 2026.

AVAH Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

AVAH Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.